BIOCONPharmaceuticals
Biocon Ltd — Balance Sheet
₹360.90
-2.52%
Biocon Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Payables | 7.89K Cr | 7.44K Cr | 4.82K Cr | 2.18K Cr | — |
| Treasury Shares Number | 0.25 Cr | 0.38 Cr | 0.66 Cr | 0.75 Cr | — |
| Ordinary Shares Number | 119.81 Cr | 119.68 Cr | 119.40 Cr | 119.31 Cr | — |
| Share Issued | 120.06 Cr | 120.06 Cr | 120.06 Cr | 120.06 Cr | — |
| Net Debt | 14.53K Cr | 14.50K Cr | 16.45K Cr | 4.24K Cr | — |
| Total Debt | 18.36K Cr | 16.28K Cr | 18.02K Cr | 5.15K Cr | — |
| Tangible Book Value | -5.41K Cr | -6.88K Cr | -8.80K Cr | 7.12K Cr | — |
| Invested Capital | 39.40K Cr | 35.51K Cr | 35.64K Cr | 13.34K Cr | — |
| Working Capital | 1.95K Cr | -179.60 Cr | 3.82K Cr | 4.55K Cr | — |
| Net Tangible Assets | -5.41K Cr | -6.88K Cr | -8.80K Cr | 7.12K Cr | — |
| Capital Lease Obligations | 606.50 Cr | 547.10 Cr | 248.10 Cr | 242.60 Cr | — |
| Common Stock Equity | 21.64K Cr | 19.78K Cr | 17.87K Cr | 8.43K Cr | — |
| Total Capitalization | 34.05K Cr | 32.72K Cr | 33.16K Cr | 12.43K Cr | — |
| Total Equity Gross Minority Interest | 27.71K Cr | 25.27K Cr | 22.49K Cr | 9.47K Cr | — |
| Minority Interest | 6.07K Cr | 5.49K Cr | 4.62K Cr | 1.04K Cr | — |
| Stockholders Equity | 21.64K Cr | 19.78K Cr | 17.87K Cr | 8.43K Cr | — |
| Other Equity Interest | 424.90 Cr | 320.10 Cr | 274.00 Cr | 204.10 Cr | — |
| Fixed Assets Revaluation Reserve | 0.90 Cr | 0.90 Cr | 0.90 Cr | 0.90 Cr | — |
| Treasury Stock | 78.40 Cr | 97.10 Cr | 97.10 Cr | 32.40 Cr | — |
| Retained Earnings | 18.96K Cr | 17.60K Cr | 16.09K Cr | 6.83K Cr | — |
| Additional Paid In Capital | 518.20 Cr | 494.00 Cr | 439.00 Cr | 384.70 Cr | — |
| Capital Stock | 600.30 Cr | 600.30 Cr | 600.30 Cr | 600.30 Cr | — |
| Common Stock | 600.30 Cr | 600.30 Cr | 600.30 Cr | 600.30 Cr | — |
| Total Liabilities Net Minority Interest | 31.08K Cr | 30.80K Cr | 29.55K Cr | 10.92K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 16.75K Cr | 15.44K Cr | 21.04K Cr | 7.10K Cr | — |
| Other Non Current Liabilities | 512.60 Cr | 310.70 Cr | 2.56K Cr | 1.22K Cr | — |
| Derivative Product Liabilities | 1.44K Cr | 329.90 Cr | 1.43K Cr | 1.52K Cr | — |
| Tradeand Other Payables Non Current | 897.00 Cr | 742.60 Cr | 658.30 Cr | — | — |
| Non Current Deferred Revenue | 336.60 Cr | 310.70 Cr | 290.10 Cr | 1.22K Cr | — |
| Non Current Deferred Taxes Liabilities | 357.70 Cr | 391.50 Cr | 381.80 Cr | 52.30 Cr | — |
| Long Term Debt And Capital Lease Obligation | 12.94K Cr | 13.42K Cr | 15.50K Cr | 4.22K Cr | — |
| Long Term Capital Lease Obligation | 539.10 Cr | 492.40 Cr | 209.10 Cr | 221.50 Cr | — |
| Long Term Debt | 12.41K Cr | 12.93K Cr | 15.29K Cr | 4.00K Cr | — |
| Long Term Provisions | 260.80 Cr | 237.60 Cr | 226.50 Cr | 91.70 Cr | — |
| Current Liabilities | 14.33K Cr | 15.36K Cr | 8.51K Cr | 3.83K Cr | — |
| Other Current Liabilities | 37.00 Cr | 2.78K Cr | 234.80 Cr | 32.00 Cr | — |
| Current Debt And Capital Lease Obligation | 5.42K Cr | 2.85K Cr | 2.52K Cr | 926.60 Cr | — |
| Current Capital Lease Obligation | 67.40 Cr | 54.70 Cr | 39.00 Cr | 21.10 Cr | — |
| Current Debt | 5.35K Cr | 2.80K Cr | 2.48K Cr | 905.50 Cr | — |
| Current Provisions | 191.60 Cr | 179.50 Cr | 148.60 Cr | 130.50 Cr | — |
| Other Payable | 932.10 Cr | 785.70 Cr | 406.10 Cr | 362.60 Cr | — |
| Dividends Payable | 0.50 Cr | 0.60 Cr | 0.40 Cr | 0.40 Cr | — |
| Total Tax Payable | 403.80 Cr | 384.00 Cr | 568.60 Cr | 205.00 Cr | — |
| Accounts Payable | 6.55K Cr | 6.27K Cr | 3.84K Cr | 1.61K Cr | — |
| Total Assets | 58.80K Cr | 56.07K Cr | 52.04K Cr | 20.39K Cr | — |
| Total Non Current Assets | 42.51K Cr | 40.89K Cr | 39.71K Cr | 12.01K Cr | — |
| Other Non Current Assets | 475.70 Cr | 428.00 Cr | 0.10 Cr | 163.10 Cr | — |
| Non Current Prepaid Assets | 269.20 Cr | 188.60 Cr | 286.90 Cr | 103.30 Cr | — |
| Non Current Deferred Taxes Assets | 257.70 Cr | 317.30 Cr | 301.00 Cr | 293.30 Cr | — |
| Financial Assets | 187.40 Cr | 265.70 Cr | 145.40 Cr | 146.80 Cr | — |
| Investmentin Financial Assets | 747.00 Cr | 754.20 Cr | 788.20 Cr | 144.70 Cr | — |
| Held To Maturity Securities | 0.00 | 0.40 Cr | 538.00 Cr | — | — |
| Available For Sale Securities | 691.00 Cr | 700.00 Cr | 195.70 Cr | 130.20 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 56.00 Cr | 54.20 Cr | 54.50 Cr | 14.50 Cr | — |
| Long Term Equity Investment | 0.00 | 0.00 | 137.80 Cr | 8.00 Cr | — |
| Goodwill And Other Intangible Assets | 27.06K Cr | 26.66K Cr | 26.66K Cr | 1.32K Cr | — |
| Other Intangible Assets | 10.27K Cr | 10.29K Cr | 10.53K Cr | 1.29K Cr | — |
| Goodwill | 16.79K Cr | 16.37K Cr | 16.14K Cr | 26.40 Cr | — |
| Net PPE | 13.61K Cr | 12.21K Cr | 10.12K Cr | 9.42K Cr | — |
| Accumulated Depreciation | -6.80K Cr | -5.92K Cr | -5.12K Cr | -4.29K Cr | — |
| Gross PPE | 20.40K Cr | 18.12K Cr | 15.24K Cr | 13.70K Cr | — |
| Construction In Progress | 4.30K Cr | 4.22K Cr | 2.59K Cr | 3.47K Cr | — |
| Other Properties | 432.20 Cr | 431.40 Cr | 391.00 Cr | 352.50 Cr | — |
| Machinery Furniture Equipment | 11.65K Cr | 9.95K Cr | 9.35K Cr | 7.31K Cr | — |
| Buildings And Improvements | 3.61K Cr | 3.16K Cr | 2.58K Cr | 2.25K Cr | — |
| Land And Improvements | 410.00 Cr | 374.70 Cr | 329.20 Cr | 317.90 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 16.29K Cr | 15.18K Cr | 12.33K Cr | 8.38K Cr | — |
| Other Current Assets | 747.40 Cr | 715.10 Cr | 588.00 Cr | 420.70 Cr | — |
| Hedging Assets Current | 96.40 Cr | 138.40 Cr | 70.40 Cr | 122.30 Cr | — |
| Restricted Cash | 2.80 Cr | 0.50 Cr | 0.60 Cr | 0.70 Cr | — |
| Prepaid Assets | 747.40 Cr | 715.10 Cr | 588.00 Cr | 420.70 Cr | — |
| Inventory | 4.93K Cr | 4.94K Cr | 4.24K Cr | 2.30K Cr | — |
| Other Inventories | 429.90 Cr | 279.80 Cr | 376.70 Cr | — | — |
| Finished Goods | 1.81K Cr | 2.41K Cr | 1.60K Cr | 380.10 Cr | — |
| Work In Process | 1.72K Cr | 1.41K Cr | 1.37K Cr | 1.06K Cr | — |
| Raw Materials | 967.90 Cr | 836.60 Cr | 896.20 Cr | 855.70 Cr | — |
| Other Receivables | 96.40 Cr | 38.90 Cr | 132.10 Cr | 1.48K Cr | — |
| Accounts Receivable | 5.49K Cr | 6.23K Cr | 3.57K Cr | 2.06K Cr | — |
| Allowance For Doubtful Accounts Receivable | -62.70 Cr | -64.60 Cr | -61.70 Cr | -36.30 Cr | — |
| Gross Accounts Receivable | 5.55K Cr | 6.30K Cr | 3.63K Cr | 2.09K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 4.92K Cr | 3.11K Cr | 3.73K Cr | 2.00K Cr | — |
| Other Short Term Investments | 1.70K Cr | 1.88K Cr | 2.40K Cr | 1.34K Cr | — |
| Cash And Cash Equivalents | 3.23K Cr | 1.23K Cr | 1.32K Cr | 662.60 Cr | — |
| Cash Equivalents | 1.28K Cr | 69.80 Cr | 36.00 Cr | 30.00 Cr | — |
| Cash Financial | 1.95K Cr | 1.16K Cr | 1.29K Cr | 632.60 Cr | — |
| Other Investments | — | — | 538.00 Cr | 262.90 Cr | 415.00 Cr |
| Assets Held For Sale Current | — | — | — | 0.00 | 52.20 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | — | — | 106.20 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Biocon Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.